Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA

Published:2012 Issue: Volume:1 Page:e37
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Belliveau Nathan M,Huft Jens,Lin Paulo JC,Chen Sam,Leung Alex KK,Leaver Timothy J,Wild Andre W,Lee Justin B,Taylor Robert J,Tam Ying K,Hansen Carl L,Cullis Pieter R

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference36 articles.

1. Drug delivery systems: entering the mainstream;Allen;Science,2004

2. Knocking down barriers: advances in siRNA delivery;Whitehead;Nat Rev Drug Discov,2009

3. Liposomal nanomedicines: an emerging field;Fenske;Toxicol Pathol,2008

4. Lipid-like materials for low-dose, in vivo gene silencing;Love;Proc Natl Acad Sci USA,2010

5. RNAi-mediated gene silencing in non-human primates;Zimmermann;Nature,2006

Cited by 503 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and production of nanoparticles;Nanotechnology Tools for Infection Control;2025

2. mRNA vaccines for COVID-19;mRNA Therapeutics;2025

3. Delivery systems for mRNA;mRNA Therapeutics;2025

4. Morphology evolution of lipid nanoparticle discovered by small angle neutron scattering;Giant;2024-12

5. Advances in the design and delivery of RNA vaccines for infectious diseases;Advanced Drug Delivery Reviews;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP